Suggestions
Michaela Dehio
Global Head Pharma DD; Development BD&L bei Novartis
Dr. Michaela Dehio is the Global Head of Pharma Due Diligence and Development Business Development & Licensing (BD&L) at Novartis, where she plays a critical role in overseeing strategic initiatives related to pharmaceutical development and partnerships. She has a strong academic background, having earned her PhD in Microbiology from Universität Köln, which underpins her expertise in the pharmaceutical industry.1
In her current position at Novartis, Dr. Dehio is involved in evaluating potential business opportunities and ensuring operational excellence within the company's strategy and growth sectors. Her work is pivotal in guiding Novartis's investment decisions and collaborations in the pharmaceutical landscape.1
Dr. Dehio's professional journey reflects a commitment to advancing healthcare through innovative drug development and strategic partnerships, aligning with Novartis's mission to improve patient outcomes globally.1
